Latest Breaking News On - Annual scientific session together - Page 2 : comparemela.com

Medtronic touts 3-year data for Evolut TAVR

Medtronic (NYSE:MDT) announced three-year data supporting its Evolut transcatheter aortic valve replacement (TAVR) system.

John forrestCorevalve evolutMedtronic evolutNina goodheartWorld heart federation congressYale school of medicineJournal of the american college cardiologyAmerican college of cardiologyEvolut low riskAmerican collegeAnnual scientific session togetherWorld heart federationWorld congressYale schoolEvolut low risk trialStructural heart

Trendy zero carb Keto diet may double risk of heart disease, study warns

The Keto diet has become incredibly popular in recent years as a rapid way to lose weight. But Canadian researchers warn that it may also raise the risk of serious cardiovascular events like a stroke.

United statesNew orleansUnited kingdomBritish columbiaLebron jamesHalle berryIulia iatanAmerican college of cardiology annual scientific sessionAmerican heart associationUniversity of british columbia centerUniversity of british columbiaWorld congressHeart lung innovationUnited kingdom biobankAmerican collegeAnnual scientific session together

Keto-like diet might double the risk of cardiovascular issues, finds new research

Since the diet is gaining popularity among the masses, it has become the subject of several research studies in recent days.

United kingdomBritish columbiaIulia iatanHealthy heart program prevention clinicAmerican college of cardiology annual scientific sessionWorld congressAmerican collegeAnnual scientific session togetherHeart lung innovationKeto like dietCardiovascular issue

Medtronic (MDT) Reports Strong Results for FDA PulseSelect PFA System in PULSED AF IDE trial

Medtronic (MDT) Reports Strong Results for FDA PulseSelect PFA System in PULSED AF IDE trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRebecca seidelAmerican college of cardiology annual scientific sessionAblation solutionsDivision of cardiologyMcgill university health centreWorld congressPulsed field ablationDevice exemptionAmerican collegeAnnual scientific session togetherPulseselect systemAtul vermaCardiac ablation solutionsCardiovascular portfolioArctic front advance

STOP-CA Clinical Trial Finds Statins Lower Rate of Heart Decline in Lymphoma Patients, Late-Breaking ACC23 Clinical Trial Reports

In conducting the “Statins to Prevent the Cardiotoxicity from Anthracyclines: The STOP-CA Trial,” researchers found that among people receiving chemotherapy regimens containing anthracyclines for lymphoma, those who took the cholesterol-lowering drug atorvastatin for one year were significantly less likely to show evidence of heart dysfunction than those who took a placebo. FIndings were reported during the first late-breaking clinical trial session during the March 4-6 American College of Cardiology’s Annual Scientific Session Together with the World Congress of Cardiology, ACC.23/WCC.

United statesMarielle scherrer crosbieTomasg neilanValentin fusterTraining program in cardiovascular imagingAscension national cardiovascular service line indianapolisProgram at massachusettsAmerican college of cardiologyAmerican college of cardiology annual scientific sessionCardiovascular imaging research programHospital of the university pennsylvaniaBlood instituteNational institutes of healthnational heart lungWorld congressEchocardiography at penn cardiovascular instituteAmerican college